[HTML][HTML] Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update

S Roumeliotis, F Mallamaci, C Zoccali - Journal of Clinical Medicine, 2020 - mdpi.com
The vascular endothelium is a dynamic, functionally complex organ, modulating multiple
biological processes, including vascular tone and permeability, inflammatory responses …

[HTML][HTML] The systemic nature of CKD

C Zoccali, R Vanholder, ZA Massy, A Ortiz… - Nature Reviews …, 2017 - nature.com
The accurate definition and staging of chronic kidney disease (CKD) is one of the major
achievements of modern nephrology. Intensive research is now being undertaken to unravel …

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

C Degirolamo, C Sabbà, A Moschetta - Nature reviews Drug discovery, 2016 - nature.com
The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for
maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism …

[HTML][HTML] FGF23 induces left ventricular hypertrophy

C Faul, AP Amaral, B Oskouei, MC Hu… - The Journal of …, 2011 - Am Soc Clin Investig
Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to
cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of …

[PDF][PDF] Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy

A Grabner, AP Amaral, K Schramm, S Singh, A Sloan… - Cell metabolism, 2015 - cell.com
Chronic kidney disease (CKD) is a worldwide public health threat that increases risk of
death due to cardiovascular complications, including left ventricular hypertrophy (LVH) …

[HTML][HTML] Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

S Singh, A Grabner, C Yanucil, K Schramm, B Czaya… - Kidney international, 2016 - Elsevier
Patients with chronic kidney disease (CKD) develop increased levels of the phosphate-
regulating hormone, fibroblast growth factor (FGF) 23, that are associated with a higher risk …

[HTML][HTML] Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

T Isakova, P Wahl, GS Vargas, OM Gutiérrez… - Kidney international, 2011 - Elsevier
Fibroblast growth factor 23 (FGF23) regulates phosphorus metabolism and is a strong
predictor of mortality in dialysis patients. FGF23 is thought to be an early biomarker of …

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

T Isakova, H Xie, W Yang, D Xie, AH Anderson… - Jama, 2011 - jamanetwork.com
Context A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-
23) is associated with mortality in patients with end-stage renal disease, but little is known …

Fibroblast growth factor-23 and cardiovascular events in CKD

JJ Scialla, H Xie, M Rahman… - Journal of the …, 2014 - journals.lww.com
An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abnormality of
mineral metabolism in CKD. High FGF-23 levels promote left ventricular hypertrophy but not …

Regulation and function of the FGF23/klotho endocrine pathways

A Martin, V David, LD Quarles - Physiological reviews, 2012 - journals.physiology.org
Calcium (Ca2+) and phosphate (PO43−) homeostasis are coordinated by systemic and local
factors that regulate intestinal absorption, influx and efflux from bone, and kidney excretion …